loadpatents
name:-0.013628005981445
name:-0.0079190731048584
name:-0.0033078193664551
RAWLINS; David Brent Patent Filings

RAWLINS; David Brent

Patent Applications and Registrations

Patent applications and USPTO patent grants for RAWLINS; David Brent.The latest application filed is for "sodium glucose co-transporter inhibitors and methods of their use".

Company Profile
2.15.16
  • RAWLINS; David Brent - Morrisville PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Sodium Glucose Co-transporter Inhibitors And Methods Of Their Use
App 20190099436 - HARRISON; Bryce Alden ;   et al.
2019-04-04
Inhibitors of sodium glucose transporter 1 for constipation
Grant 10,106,569 - Carson , et al. October 23, 2
2018-10-23
Inhibitors Of Sodium Glucose Cotransporter 1
App 20180244708 - CARSON; Kenneth Gordon ;   et al.
2018-08-30
Inhibitors of sodium glucose cotransporter 1
Grant 9,688,710 - Carson , et al. June 27, 2
2017-06-27
Sodium Glucose Co-transporter Inhibitors And Methods Of Their Use
App 20170087172 - HARRISON; Bryce Alden ;   et al.
2017-03-30
Inhibitors Of Sodium Glucose Cotransporter 1
App 20160326205 - CARSON; Kenneth Gordon ;   et al.
2016-11-10
Sodium glucose co-transporter inhibitors and methods of their use
Grant 9,365,602 - Harrison , et al. June 14, 2
2016-06-14
Inhibitors of sodium glucose cotransporter 1
Grant 9,200,025 - Carson , et al. December 1, 2
2015-12-01
Inhibitors Of Sodium Glucose Cotransporter 1
App 20140309178 - CARSON; Kenneth Gordon ;   et al.
2014-10-16
Sodium Glucose Co-transporter Inhibitors And Methods Of Their Use
App 20140135277 - HARRISON; Bryce Alden ;   et al.
2014-05-15
Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors
Grant 8,507,672 - Harrison , et al. August 13, 2
2013-08-13
Sulfanyl-tetrahydropyran-based compounds and methods of their use
Grant 8,476,413 - Harrison , et al. July 2, 2
2013-07-02
LIMK2 inhibitors, compositions comprising them, and methods of their use
Grant 8,450,332 - Burgoon , et al. May 28, 2
2013-05-28
5-(1h-pyrazol-5-yl)thiazole-based Compounds For The Treatment Of Diseases And Disorders Of The Eye
App 20130059896 - Goodwin; Nicole Cathleen ;   et al.
2013-03-07
Limk2 Inhibitors, Compositions Comprising Them, And Methods Of Their Use
App 20120329818 - BURGOON; Hugh Alfred ;   et al.
2012-12-27
LIMK2 inhibitors, compositions comprising them, and methods of their use
Grant 8,193,202 - Burgoon , et al. June 5, 2
2012-06-05
Sulfanyl-tetrahydropyran-based Compounds And Methods Of Their Use
App 20100311673 - Harrison; Bryce Alden ;   et al.
2010-12-09
Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use
Grant 7,846,945 - Harrison , et al. December 7, 2
2010-12-07
Inhibitors of sodium glucose co-transporter 2 and methods of their use
Grant 7,781,577 - Harrison , et al. August 24, 2
2010-08-24
Limk2 Inhibitors, Compositions Comprising Them, And Methods Of Their Use
App 20090264450 - Burgoon; Hugh Alfred ;   et al.
2009-10-22
Kinase Inhibitors, Compositions Comprising Them, And Methods Of Their Use
App 20090042893 - Harrison; Bryce Alden ;   et al.
2009-02-12
Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
App 20080221164 - Goodwin; Nicole C. ;   et al.
2008-09-11
4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds
Grant 7,423,043 - Rawlins , et al. September 9, 2
2008-09-09
Inhibitors Of Sodium Glucose Co-transporter 2 And Methods Of Their Use
App 20080113922 - Harrison; Bryce Alden ;   et al.
2008-05-15
4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds
App 20060189638 - Rawlins; David Brent ;   et al.
2006-08-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed